|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online November 18, 2003
doi: 10.1242/10.1242/jcs.00918
Research Article |
1 Molecular Neuropathobiology Laboratory, Cancer Research UK, London Research Institute, Lincoln's Inn Fields Laboratories, 44 Lincoln's Inn Fields, London WC2A 3PX, UK
2 Department of Biology, University of Utah, Salt Lake City, Utah 84112-0840, USA
3 Center for C. elegans Anatomy, Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York 10461, USA
4 Nutrition and Metabolism Research Group, University of Alberta, Edmonton, Alberta, T6G 2P5, Canada
5 EleGene AG, Am Klopferspitz 19, 82152 Martinsried, Germany
Author for correspondence: (e-mail: giovanni.lesa{at}ucl.ac.uk)
Accepted 2 October 2003
The complex lipid constituents of the eukaryotic plasma membrane are precisely controlled in a cell-type-specific manner, suggesting an important, but as yet, unknown cellular function. Neuronal membranes are enriched in long-chain polyunsaturated fatty acids (LC-PUFAs) and alterations in LC-PUFA metabolism cause debilitating neuronal pathologies. However, the physiological role of LC-PUFAs in neurons is unknown. We have characterized the neuronal phenotype of C. elegans mutants depleted of LC-PUFAs.
The C. elegans genome encodes a single 
6-desaturase gene (fat-3), an essential enzyme for LC-PUFA biosynthesis. Animals lacking fat-3 function do not synthesize LC-PUFAs and show movement and egg-laying abnormalities associated with neuronal impairment. Expression of functional fat-3 in neurons, or application of exogenous LC-PUFAs to adult animals rescues these defects. Pharmacological, ultrastructural and electrophysiological analyses demonstrate that fat-3 mutant animals are depleted of synaptic vesicles and release abnormally low levels of neurotransmitter at cholinergic and serotonergic neuromuscular junctions. These data indicate that LC-PUFAs are essential for efficient neurotransmission in C. elegans and may account for the clinical conditions associated with mis-regulation of LC-PUFAs in humans.
Key words: C. elegans, Neuromuscular junction, Neurotransmitter release, Polyunsaturated fatty acids, Synapse
Related articles in JCS:
This article has been cited by other articles:
|
|
 |
|
  M. Horikawa, T. Nomura, T. Hashimoto, and K. Sakamoto Elongation and Desaturation of Fatty Acids are Critical in Growth, Lipid Metabolism and Ontogeny of Caenorhabditis elegans J. Biochem., August 1, 2008; 144(2): 149 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. V. Entchev, D. Schwudke, V. Zagoriy, V. Matyash, A. Bogdanova, B. Habermann, L. Zhu, A. Shevchenko, and T. V. Kurzchalia LET-767 Is Required for the Production of Branched Chain and Long Chain Fatty Acids in Caenorhabditis elegans J. Biol. Chem., June 20, 2008; 283(25): 17550 - 17560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Marza, T. Long, A. Saiardi, M. Sumakovic, S. Eimer, D. H. Hall, and G. M. Lesa Polyunsaturated Fatty Acids Influence Synaptojanin Localization to Regulate Synaptic Vesicle Recycling Mol. Biol. Cell, March 1, 2008; 19(3): 833 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Darios, E. Connell, and B. Davletov Phospholipases and fatty acid signalling in exocytosis J. Physiol., December 15, 2007; 585(3): 699 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Caspi, B. Williams, J. Kim-Cohen, I. W. Craig, B. J. Milne, R. Poulton, L. C. Schalkwyk, A. Taylor, H. Werts, and T. E. Moffitt Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism PNAS, November 20, 2007; 104(47): 18860 - 18865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Brock, J. Browse, and J. L. Watts Fatty Acid Desaturation and the Regulation of Adiposity in Caenorhabditis elegans Genetics, June 1, 2007; 176(2): 865 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Taubert, M. R. Van Gilst, M. Hansen, and K. R. Yamamoto A Mediator subunit, MDT-15, integrates regulation of fatty acid metabolism by NHR-49-dependent and -independent pathways in C. elegans. Genes & Dev., May 1, 2006; 20(9): 1137 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. M. Choy, J. M. Kemner, and J. H. Thomas Fluoxetine-Resistance Genes in Caenorhabditis elegans Function in the Intestine and May Act in Drug Transport Genetics, February 1, 2006; 172(2): 885 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C McCann and B. N Ames Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals Am. J. Clinical Nutrition, August 1, 2005; 82(2): 281 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kitajka, A. J. Sinclair, R. S. Weisinger, H. S. Weisinger, M. Mathai, A. P. Jayasooriya, J. E. Halver, and L. G. Puskas Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression PNAS, July 27, 2004; 101(30): 10931 - 10936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Wenk and P. De Camilli Inaugural Article: Protein-lipid interactions and phosphoinositide metabolism in membrane traffic: Insights from vesicle recycling in nerve terminals PNAS, June 1, 2004; 101(22): 8262 - 8269. [Abstract] [Full Text] [PDF]
|
|
